PGNX - Progenics Pharmaceuticals misses by $0.02 beats on revenue May, 09 2019 07:46 AM Progenics Pharmaceuticals Inc. Progenics Pharmaceuticals (NASDAQ:PGNX): Q1 GAAP EPS of -$0.22 misses by $0.02.More news on: Progenics Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...